Mansour-Ghanaei F - Search Results

1

The common variant of rs6214 in insulin like growth factor 1 (IGF1) gene: a potential protective factor for non-alcoholic fatty liver disease.

Sabzikarian M, Mahmoudi T, Tabaeian SP, Rezamand G, Asadi A, Farahani H, Nobakht H, Dabiri R, Mansour-Ghanaei F, Derakhshan F, Zali MR. Sabzikarian M, et al. Arch Physiol Biochem. 2023 Feb;129(1):10-15. doi: 10.1080/13813455.2020.1791187. Epub 2020 Jul 11. Arch Physiol Biochem. 2023. PMID: 32654522

2

Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran.

Malekzadeh MM, Vahedi H, Gohari K, Mehdipour P, Sepanlou SG, Ebrahimi Daryani N, Zali MR, Mansour-Ghanaei F, Safaripour A, Aghazadeh R, Vossoughinia H, Fakheri H, Somi MH, Maleki I, Hoseini V, Ghadir MR, Daghaghzadeh H, Adibi P, Tavakoli H, Taghavi A, Zahedi MJ, Amiriani T, Tabib M, Alipour Z, Nobakht H, Yazdanbod A, Sadreddini M, Bakhshipour A, Khosravi A, Khosravi P, Nasseri-Moghaddam S, Merat S, Sotoudehmanesh R, Barazandeh F, Arab P, Baniasadi N, Pournaghi SJ, Parsaeian M, Farzadfar F, Malekzadeh R. Malekzadeh MM, et al. Arch Iran Med. 2016 Jan;19(1):2-15. Arch Iran Med. 2016. PMID: 26702742 Review.

3

Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial.

Mansour-Ghanaei F, Samadi A, Joukar F, Tirgar Fakheri H, Hassanipour S, Ashoobi MT, Soltanipour S, Alizadeh A, Rezamand G, Fathalipour M. Mansour-Ghanaei F, et al. EXCLI J. 2019 Aug 19;18:644-652. doi: 10.17179/excli2019-1613. eCollection 2019. EXCLI J. 2019. PMID: 31611747 Free PMC article.

4

A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease.

Dabiri R, Mahmoudi T, Sabzikarian M, Asadi A, Farahani H, Nobakht H, Maleki I, Mansour-Ghanaei F, Derakshshan F, Zali MR. Dabiri R, et al. Acta Gastroenterol Belg. 2020 Apr-Jun;83(2):271-276. Acta Gastroenterol Belg. 2020. PMID: 32603046 Free article.

5

INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE.

Nobakht H, Mahmoudi T, Sabzikarian M, Tabaeian SP, Rezamand G, Asadi A, Farahani H, Dabiri R, Mansour-Ghanaei F, Maleki I, Zali MR. Nobakht H, et al. Arq Gastroenterol. 2020 Apr-Jun;57(2):203-208. doi: 10.1590/S0004-2803.202000000-39. Arq Gastroenterol. 2020. PMID: 33206859 Free article.

6

The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease.

Tabaeian SP, Mahmoudi T, Sabzikarian M, Rezamand G, Dabiri R, Nobakht H, Asadi A, Farahani H, Mansour-Ghanaei F, Zali MR. Tabaeian SP, et al. J Gastrointestin Liver Dis. 2021 Jun 19;30(2):233-239. doi: 10.15403/jgld-2703. J Gastrointestin Liver Dis. 2021. PMID: 34174062 Free article.

7

The "GG" genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease.

Rezamand G, Mahmoudi T, Tabaeian SP, Farahani H, Shahinmehr F, Nobakht H, Dabiri R, Asadi A, Mansour-Ghanaei F, Zali MR. Rezamand G, et al. Physiol Int. 2021 Sep 16;108(3):342-352. doi: 10.1556/2060.2021.00183. Physiol Int. 2021. PMID: 34529585

8

Association of rs5742612 Polymorphism in the Promoter Region of IGF1 Gene with Nonalcoholic Fatty Liver Disease: A Case-Control Study.

Nobakht H, Mahmoudi T, Rezamand G, Tabaeian SP, Jeddi G, Asadi A, Farahani H, Dabiri R, Mansour-Ghanaei F, Kaboli SA, Derakhshan F, Zali MR. Nobakht H, et al. Lab Med. 2022 Sep 1;53(5):504-508. doi: 10.1093/labmed/lmac039. Lab Med. 2022. PMID: 35713614

9

The effectiveness of walking exercise on the bowel preparation before colonoscopy: a single blind randomized clinical trial study.

Rezamand G, Joukar F, Amini-Salehi E, Delam H, Zare R, Samadi A, Mavadati S, Hassanipour S, Mansour-Ghanaei F. Rezamand G, et al. BMC Gastroenterol. 2023 Oct 9;23(1):351. doi: 10.1186/s12876-023-02987-x. BMC Gastroenterol. 2023. PMID: 37814210 Free PMC article. Clinical Trial.

10

The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review.

Vakilpour A, Amini-Salehi E, Soltani Moghadam A, Keivanlou MH, Letafatkar N, Habibi A, Hashemi M, Eslami N, Zare R, Norouzi N, Delam H, Joukar F, Mansour-Ghanaei F, Hassanipour S, Samethadka Nayak S. Vakilpour A, et al. Among authors: mansour ghanaei f. Nutr Diabetes. 2024 May 10;14(1):25. doi: 10.1038/s41387-024-00281-7. Nutr Diabetes. 2024. PMID: 38729941 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page